Sleep Cycle board recommends rejecting Altor's cash offer
The board states the SEK 24.50 per share offer undervalues the company's growth prospects and subscription business.
See the latest news and media coverage for Sleep Cycle. We track all announcements, press releases, and industry mentions in real time, all in one place.
Mobile sleep-tracking and sleep-improvement app
sleepcycle.comLast updated
In short: Sleep Cycle's board recommended rejecting a SEK 24.50 per share cash offer from Altor, stating it significantly undervalued the company's prospects.
The board states the SEK 24.50 per share offer undervalues the company's growth prospects and subscription business.
The offer is SEK 24.50 per share cash. Board will announce opinion before acceptance period.
B2B revenue grows 42% to 14.5% of total. Net sales decrease 19%. Organizational changes announced. Sleep apnea study progresses.
It is the only OTC solution without a wearable for proactive risk detection. The tool awaits CE and FDA clearance.
Sleep Cycle's fifth largest owner Lancelot Asset Management believes that Altors bid 'significantly undervalues Sleep Cycle's assets and future...'
Sleep Cycle is accelerating its transformation from sleep app to platform within sleep and digital health. In the first quarter of 2026, B2B revenue grew...
Sleep Cycle, which offers an app for sleep analysis, reports an operating result of 6.7 million kronor (17.1) for the first quarter of 2026.
At the Annual General Meeting (the "AGM") of Sleep Cycle AB (publ) on 13 April 2026, the following was resolved. Adoption of the income statement...
Track Sleep Cycle and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Sleep Cycle and other trending companies.